| advertise add site services publishers database health videos | ![]() | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
![]()
LifeCycle Pharma Promotes Dr. William J. Polvino as New President and Chief ...Benzinga - 12 hours ago ... and bioavailability - at low-scale up costs - not only for a broad spectrum of drugs already on the market but also for new chemical entities. ... Glenmark Pharma to outlicense NCEsBusiness Standard - - Nov 30, 2009 Glenmark Pharmaceuticals is confident of outlicensing at least one of its new chemical entities (NCEs) under development before the end of this financial ... Suven gets patents from EPO for 3 drugsBusiness Standard - Nov 30, 2009 With these new patents, Suven has total of seven granted EPO patents on new chemical entities. These granted patents are exclusive intellectual property of ... EPO Awards 3 Patents to 3 Suven Drugs Stock Watch Sepracor to Present New STEDESA™ Clinical Data at American Epilepsy Society ...Earthtimes (press release) - 8 hours ago A PDUFA date is the date by which the FDA is expected to review and act on a New Drug Application (NDA) submission. STEDESA, a new chemical entity, ... Do-Buy on Dalal Street…Nifty regains 5kIndia Infoline.com - - Nov 30, 2009 ... announced that the European Patent Office (EPO) Issued 3 new Patents: EP1537113, EP1704154 and EP1856132 corresponding to three New Chemical Entities ... More Than Genes III: Pregnancy, Toxic Environments, and Fetal VulnerabilityHuffington Post (blog) - Dec 1, 2009 ... indeed recognizable as a vaguely human form, but still small enough for simple diffusion to quickly distribute any permeating chemical entity throughout ... Ranbaxy: FDA Issues Will Take Long Time To ResolveWall Street Journal - - Nov 9, 2009 "It'll be a comprehensive arrangement, which will cover manufacturing and even new chemical entities," Sobti said. The new chemical entities are molecules ... Ongoing FDA issues aren't stopping Ranbaxy FiercePharma Markets up on Asian cuesEquitymaster.com - Nov 30, 2009 As per a leading business daily, Glenmark Pharma plans to outlicense at least one of its new chemical entities (nces) under development this fiscal. ... New Report "Stem Cells – The Hype & Hope – World Analysis 2009-2024" available ...Online PR News (press release) - Nov 23, 2009 Stem cell lines could also change the way pharmaceutical companies assess new chemical entities during R&D. A conservative estimate places the potential ... NicOx launches a E70 million rights issueEuronext (persbericht) - Nov 24, 2009 NicOx's strategy is to leverage its world-leading R&D platform and expertise in developing nitric oxide-donating New Chemical Entities (NCEs) to become a ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests... Bernard von NotHaus (Liberty Dollar) Aubrey de Grey, PhD Dr. Amanuel Sima, MD Dr. Bard Levey, DDS Neal Adams Robin Scovill (director) Richard Diaz (author) Dr. Kaayla T. Daniel, CCN Chana de Wolf, (cryonics researcher) Dr. Mary Ruwart (author & scientist) Richard Diaz (author) Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |